Stefanie D. Krämer

5.9k citations

172 papers · 4.4k indexed · h-index 40

Impact in

Pharmaceutical Science top 2%
Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism

Papers in

Clinical Biochemistry 12
- Metabolism and Genetic Disorders 12
Cellular and Molecular Neuroscience 27
- Neuroscience and Neuropharmacology Research 20

Co-authors: Bernard Testa Heidi Wunderli‐Allenspach Roger Schibli Simon M. Ametamey Linjing Mu David M. Becker Adrienne Müller Adrienne Müller Herde
Journals: Chemistry & Biodiversity (10 papers)Pharmaceutical Research (9 papers)Journal of Nuclear Medicine (9 papers)Journal of Medicinal Chemistry (7 papers)European Journal of Pharmaceutical Sciences (6 papers)
Partner nations: Switzerland South Africa Germany

In The Last Decade

Stefanie D. Krämer

171 papers receiving 4.3k citations

Peers

Countries citing papers authored by Stefanie D. Krämer

Since Specialization

Citations

This map shows the geographic impact of Stefanie D. Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie D. Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie D. Krämer more than expected).

Fields of papers citing papers by Stefanie D. Krämer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie D. Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie D. Krämer. The network helps show where Stefanie D. Krämer may publish in the future.

Co-authors

The 25 scholars most cited alongside Stefanie D. Krämer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefanie D. Krämer Line = papers co-authored together Stefanie D. Krämer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Towards imaging the immune state of cancer by PET: Targeting legumain with 11C-labeled P1-Asn peptidomimetics carrying a cyano-warhead Nuclear Medicine and Biology ·ANDY KISER, М Ю Карганов, Tobias Alves., Richard D. Williams, Roger Schibli, Linjing Mu, Stefanie D. Krämer	2024	2
2	Size of lipid emulsion droplets influences metabolism in human CD4+ T cells Biochemical and Biophysical Research Communications ·René Arne Bergmann, Dean Notabartolo, Paulina Wawrzyniak, Бағлан Мизамхан, Stefanie D. Krämer, Gerhard Rogler, Eliana Lucchinetti, Michael Zaugg, Martin Hersberger	2024	1
3	Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial BMJ Open ·H Bemm, Amanda Zaluckyj, Stefanie D. Krämer, Fouzia Saeed, S. Micotti, Jessica Kaufeld, Armin Koch, Dagmar Hartung, Bernhard M. W. Schmidt, Kai M. Schmidt‐Ott, Roland Schmitt	2024	5
4	Crosstalk within peripheral blood mononuclear cells mediates anti-inflammatory effects of n-3 PUFA-rich lipid emulsions in parenteral nutrition Clinical Nutrition ·Paulina Wawrzyniak, Tahir Ullah, Marcin Wawrzyniak, René Arne Bergmann, Titik Yuliana, Sylvie Scharl, Matthias Turina, Michael Scharl, Michael Zaugg, Stefanie D. Krämer, Gerhard Rogler, Martin Hersberger	2023	2
5	Identification of (R)-[¹⁸F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development Journal of Nuclear Medicine ·Raine Ngo, Stefanie D. Krämer, Uwe Grether, Matthias Wittwer, Ludovic Collin, Bernd Kuhn, N. Borodin, Dominik Heer, Fionn O’Hara, Michael Honer, Anto Pavlovic, Hans Richter, Martin Ritter, G. Jumarie, Claudia Keller, Luca Gobbi, Linjing Mu	2023	1
6	Lipid emulsion rich in n–3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells American Journal of Clinical Nutrition ·René Arne Bergmann, Lea El Essrawi, Paulina Wawrzyniak, Бағлан Мизамхан, Phing‐How Lou, Eliana Lucchinetti, Stefanie D. Krämer, Gerhard Rogler, Michael Zaugg, Martin Hersberger	2022	14
7	Gut microbiome and circulating bacterial DNA (“blood microbiome”) in a mouse model of total parenteral nutrition: Evidence of two distinct separate microbiotic compartments Clinical Nutrition ESPEN ·Eliana Lucchinetti, Phing‐How Lou, Anisimov Jz, Lukas Bestmann, Martin Hersberger, Gerhard Rogler, Stefanie D. Krämer, Michael Zaugg	2022	10
8	Novel lipid emulsion for total parenteral nutrition based on 18-carbon n–3 fatty acids elicits a superior immunometabolic phenotype in a murine model compared with standard lipid emulsions American Journal of Clinical Nutrition ·Eliana Lucchinetti, Phing‐How Lou, Dean Notabartolo, René Arne Bergmann, Paulina Wawrzyniak, Lea El Essrawi, Megan Lee, 勝美大平, Xavier Clemente‐Casares, Sue Tsai, Gerhard Rogler, Stefanie D. Krämer, Martin Hersberger, Michael Zaugg	2022	11
9	Changes of cerebral network activity after invasive stimulation of the mesencephalic locomotor region in a rat stroke model Experimental Neurology ·Stefanie D. Krämer, Michael K. Schuhmann, 洋平松延, Ina Israel, Samuel Samnick, Jens Volkmann, Felix Fluri	2021	4
10	Novel Strategies to Prevent Total Parenteral Nutrition‐Induced Gut and Liver Inflammation, and Adverse Metabolic Outcomes Molecular Nutrition & Food Research ·Eliana Lucchinetti, Phing‐How Lou, Paulina Wawrzyniak, Marcin Wawrzyniak, Michael Scharl, Dean Notabartolo, Stefanie D. Krämer, Martin Hersberger, Gerhard Rogler, Michael Zaugg	2020	18
11	Nutritional Lipids and Mucosal Inflammation Molecular Nutrition & Food Research ·Paulina Wawrzyniak, René Arne Bergmann, Marcin Wawrzyniak, Eliana Lucchinetti, Stefanie D. Krämer, Gerhard Rogler, Michael Zaugg, Martin Hersberger	2020	32
12	Choice of Lipid Emulsion Determines Inflammation of the Gut‐Liver Axis, Incretin Profile, and Insulin Signaling in a Murine Model of Total Parenteral Nutrition Molecular Nutrition & Food Research ·Phing‐How Lou, Eliana Lucchinetti, Paulina Wawrzyniak, Yasser Morsy, Marcin Wawrzyniak, Michael Scharl, Stefanie D. Krämer, Gerhard Rogler, Martin Hersberger, Michael Zaugg	2020	9
13	Evaluation of¹¹C-Me-NB1 as a Potential PET Radioligand for Measuring GluN2B-Containing NMDA Receptors, Drug Occupancy, and Receptor Cross Talk Journal of Nuclear Medicine ·Stefanie D. Krämer, S.Kh. Kambarbekov, Linjing Mu, Ahmed Haider, Adrienne Müller Herde, Ibsaini Ibsaini, Claudia Keller, A. Bittar, Roger Schibli, Bernhard Wünsch, Simon M. Ametamey	2017	32
14	A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5 European Journal of Nuclear Medicine and Molecular Imaging ·Geoffrey Warnock, Michael Sommerauer, Linjing Mu, Fozia S. Qazi, Д. Н. Родионова, Valérie Treyer, Roger Schibli, Alfred Buck, Stefanie D. Krämer, Simon M. Ametamey	2017	16
15	Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [ 11 C]RS-016 targeting CB2 in atherosclerosis Nuclear Medicine and Biology ·蔡银香, Roger Slavik, Linjing Mu, Zoran Rančić, Nicole Borel, Roger Schibli, Simon M. Ametamey, Stefanie D. Krämer, Adrienne Müller Herde	2017	22
16	Radiofluorinated histamine H3 receptor antagonist as a potential probe for in vivo PET imaging: Radiosynthesis and pharmacological evaluation Bioorganic & Medicinal Chemistry ·Ουρανία Νάτση, Michael Honer, Antoine-Frédéric Bernhard, Zhao Qihuan, Holger Stark, Stefanie D. Krämer, P. August Schubiger, Simon M. Ametamey	2012	9
17	Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands Bioorganic & Medicinal Chemistry ·Jowhara AlQahtani, Linjing Mu, F. Underwood, Stefanie D. Krämer, Michael Honer, P. August Schubiger, Simon M. Ametamey	2010	17
18	Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis Molecular and Cellular Biochemistry ·Giovanni Di Maira, Stephen Kachman-D., Iu Ia Burshteĭn, Sara Belli, Stefanie D. Krämer, Lorenzo A. Pinna, Maria Ruzzene	2008	26
19	LIPIDS IN BLOOD–BRAIN BARRIER MODELS IN VITRO I: THIN-LAYER CHROMATOGRAPHY AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY FOR THE ANALYSIS OF LIPID CLASSES AND LONG-CHAIN POLYUNSATURATED FATTY ACIDS In Vitro Cellular & Developmental Biology - Animal ·Stefanie D. Krämer, Kayo Aoyama, N. Joan Abbott, David J. Begley	2002	22
20	Physicochemical properties in pharmacokinetic lead optimization Il Farmaco ·Stefanie D. Krämer, Heidi Wunderli‐Allenspach	2001	39

About Stefanie D. Krämer

Stefanie D. Krämer is a scholar working on Clinical Biochemistry, Cellular and Molecular Neuroscience, Pharmacology, Molecular Biology and Biochemistry, having authored 172 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (22 papers), Porphyrin Metabolism and Disorders (21 papers), Drug Transport and Resistance Mechanisms (20 papers), Neuroscience and Neuropharmacology Research (20 papers), Heme Oxygenase-1 and Carbon Monoxide (16 papers), Neonatal Health and Biochemistry (12 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Metabolism and Genetic Disorders (12 papers). The work is most often cited by research in Pharmaceutical Science (234 citations), Pharmacology (317 citations), Molecular Biology (2.1k citations), Cellular and Molecular Neuroscience (538 citations) and Biological Psychiatry (73 citations). Stefanie D. Krämer has collaborated with scholars based in Switzerland, South Africa and Germany. Frequent co-authors include Bernard Testa, Heidi Wunderli‐Allenspach, Roger Schibli, Simon M. Ametamey, Linjing Mu, David M. Becker, Adrienne Müller, Adrienne Müller Herde, Maja Günthert and Annette Braun. Their work appears in journals such as Chemistry & Biodiversity, Pharmaceutical Research, Journal of Nuclear Medicine, Journal of Medicinal Chemistry and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact